Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness

被引:209
|
作者
Liao, Tsai-Tsen [1 ]
Yang, Muh-Hwa [1 ,2 ,3 ]
机构
[1] Natl Yang Ming Univ, Inst Clin Med, 155,Sec 2,Li Nong St, Taipei 112, Taiwan
[2] Natl Yang Ming Univ, Genome Res Ctr, Taipei, Taiwan
[3] Taipei Vet Gen Hosp, Dept Oncol, Div Med Oncol, Taipei, Taiwan
关键词
epithelial-mesenchymal transition; metastasis; plasticity; stemness; CIRCULATING TUMOR-CELLS; SMAD-INTERACTING PROTEIN-1; TRANSCRIPTION FACTOR SNAIL; GROWTH-FACTOR RECEPTOR; E-CADHERIN REPRESSION; REGULATES E-CADHERIN; EMT-ACTIVATOR ZEB1; GENE-EXPRESSION; MIR-200; FAMILY; PROSPECTIVE IDENTIFICATION;
D O I
10.1002/1878-0261.12096
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Epithelial-mesenchymal transition (EMT) is an important process in embryonic development, fibrosis, and cancer metastasis. During cancer progression, the activation of EMT permits cancer cells to acquire migratory, invasive, and stem-like properties. A growing body of evidence supports the critical link between EMT and cancer stemness. However, contradictory results have indicated that the inhibition of EMT also promotes cancer stemness, and that mesenchymal-epithelial transition, the reverse process of EMT, is associated with the tumor-initiating ability required for metastatic colonization. The concept of 'intermediate-state EMT' provides a possible explanation for this conflicting evidence. In addition, recent studies have indicated that the appearance of 'hybrid' epithelial-mesenchymal cells is favorable for the establishment of metastasis. In summary, dynamic changes or plasticity between the epithelial and the mesenchymal states rather than a fixed phenotype is more likely to occur in tumors in the clinical setting. Further studies aimed at validating and consolidating the concept of intermediate-state EMT and hybrid tumors are needed for the establishment of a comprehensive profile of cancer metastasis.
引用
收藏
页码:792 / 804
页数:13
相关论文
共 50 条
  • [1] Epithelial-mesenchymal plasticity in breast cancer metastasis
    Kang, Yibin
    CANCER RESEARCH, 2013, 73
  • [2] Epithelial-mesenchymal Plasticity in Breast Cancer Metastasis
    T Blick
    C A Pinto
    D Huang
    A Tachtsidis
    E Widodo
    H Hugo
    R Wafai
    D Gunasinghe
    I Haviv
    M E Lenburg
    R M Neve
    DF Newgreen
    ML Ackland
    M Waltham
    E W Thompson
    中国肺癌杂志, 2009, 12 (06) : 1 - 2
  • [3] EPITHELIAL-MESENCHYMAL TRANSITION AND STEMNESS PLASTICITY ARE EARLY EVENTS IN HEPATOCARCINOGENESIS
    Santo, Joana Espirito
    Ladeirinha, Ana
    Alarcao, Ana
    Neves, Lia
    Strelet, Eugeniu
    Reis, Marco
    Santos, Rui
    Carvalho, Lina
    HEPATOLOGY, 2021, 74 : 688A - 689A
  • [4] Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis
    Lu, Wei
    Kang, Yibin
    DEVELOPMENTAL CELL, 2019, 49 (03) : 361 - 374
  • [5] MET: roles in epithelial-mesenchymal transition and cancer stemness
    Jeon, Hye-Min
    Lee, Jeongwu
    ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (01)
  • [6] Epithelial-mesenchymal transition in cancer stemness and heterogeneity: updated
    Keywan Mortezaee
    Jamal Majidpoor
    Ebrahim Kharazinejad
    Medical Oncology, 39
  • [7] Epithelial-mesenchymal transition and cancer stemness: the Twist1-Bmi1 connection
    Wu, Kou-Juey
    Yang, Muh-hwa
    BIOSCIENCE REPORTS, 2011, 31 (06) : 449 - 455
  • [8] Controversies around epithelial-mesenchymal plasticity in cancer metastasis
    Williams, Elizabeth D.
    Gao, Dingcheng
    Redfern, Ndrew
    Thompson, Erik W.
    NATURE REVIEWS CANCER, 2019, 19 (12) : 716 - 732
  • [9] Epithelial-mesenchymal plasticity in carcinoma metastasis
    Tsai, Jeff H.
    Yang, Jing
    GENES & DEVELOPMENT, 2013, 27 (20) : 2192 - 2206
  • [10] Revisiting mTOR and Epithelial-Mesenchymal Transition
    Herrerias, Mariana M.
    Budinger, G. R. Scott
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2020, 62 (06) : 669 - 670